Good practices recommended by the Belgian Financial Services and Markets Authority (FSMA)

What are the best practices for biotech companies in relation to inside information and the Belgian Financial Services and Markets

How does the Belgian Financial Services and Markets Authority (FSMA) determine what qualifies as inside information for biotech companies?

In applying the insufficiency principles laid down in Regeneron, the High Court highlights some key considerations for patentees looking to

The updated wage subsidy scheme contains new details and differences to NOW 2.0 and 1.0

For businesses looking to satisfy financial covenants in difficult conditions, as well as those looking to re-finance, the interpretation of

The UK government has set out its Winter Economy Plan, its latest stimulus package which provides more targeted support for

The chancellor has announced new measures for employers to support jobs when the Coronavirus Job Retention Scheme (CJRS) ends on

London markets have remained open during the pandemic allowing for a surge in life sciences and healthcare sector deals including

Will we ever see the Unified Patent Court operate? Many have doubts, as its path – already long and difficult